Successful Treatment with Dupilumab in a Patient with Severe, Difficult to Treat Atopic Dermatitis: Beware of Symptomatic Adrenal Insufficiency due to Abrupt Discontinuation of Pot... by Lieneke F.M. Ariëns, Jorien van der Schaft, Aline M.E. Stades, Anthonie A. van de Woestijne, Marjolein S. De Bruin-Weller

Connect to this object online.

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment by Lieneke F.M. Ariëns, Kirsten J.M. van Nimwegen, Marjan Shams, Digna T. de Bruin, Jorien van der Schaft, Harmieke van Os-Medendorp, Marjolein De Bruin-Weller

Connect to this object online.

Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema by Floor M. Garritsen, Jorien van der Schaft, Marlies de Graaf, Dirk Jan Hijnen, Carla A.F. Bruijnzeel-Koomen, Marcel P.H. van den Broek, Marjolein S. De Bruin-Weller

Connect to this object online.

Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry by Lieneke F.M. Ariëns, Daphne S. Bakker, Lotte S. Spekhorst, Jorien van der Schaft, Judith L. Thijs, Inge Haeck, Annebeth E. Flinterman, Marijke Kamsteeg, Marie L.A. Schuttelaar, Marjolein S. De Bruin-Weller

Connect to this object online.

Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs by Floor M. Garritsen, Jorien van der Schaft, Juul M. Reek, Klaziena Politiek, Harmieke van den Os-Medendorp, Marijke van Dijk, Dirk J. Hijnen, Marlies de Graaf, Carla A. Bruijnzeel-Koomen, Elke M. de Jong, Marie-Louise A. Schuttelaar, Marjolein S. Bruin-Weller

Connect to this object online.